polygenic risk score cohort
Evidence from:
primary |
all sources
Related entities (69)
Mentioned in (46)
Papers in which this entity is mentioned.
- Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium. (2026)
- The Impact of Polygenic Risk, Parental Separation, and Parental Relationship Discord on Heavy Episodic Drinking Across Adolescence and Young Adulthood in a High-Risk Sample. (2025)
- Concordance between male- and female-specific GWAS results helps define underlying genetic architecture of complex traits. (2025)
- Trajectories of genetic risk across dimensions of alcohol use behaviors. (2025)
- Genome-wide association testing beyond SNPs. (2025)
- Improving polygenic risk prediction in admixed populations by explicitly modeling ancestral-differential effects via GAUDI. (2024)
- BridgePRS leverages shared genetic effects across ancestries to increase polygenic risk score portability. (2024)
- MUSSEL: Enhanced Bayesian polygenic risk prediction leveraging information across multiple ancestry groups. (2024)
- Alcohol Use Disorder Polygenic Score Compared With Family History and ADH1B. (2024)
- Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases. (2024)
- Principles and methods for transferring polygenic risk scores across global populations. (2024)
- Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. (2024)
- CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods. (2024)
- The Polygenic Score Catalog: new functionality and tools to enable FAIR research. (2024)
- Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. (2024)
- Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium. (2024)
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- Biobank-scale methods and projections for sparse polygenic prediction from machine learning. (2023)
- Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary. (2023)
- Pitfalls of predicting age-related traits by polygenic risk scores. (2023)
- Predicting Alcohol-Related Memory Problems in Older Adults: A Machine Learning Study with Multi-Domain Features. (2023)
- Polygenic scoring accuracy varies across the genetic ancestry continuum. (2023)
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Genetic Influences on the Developing Young Brain and Risk for Neuropsychiatric Disorders. (2023)
- Research Review: A guide to computing and implementing polygenic scores in developmental research. (2022)
- Parsing genetically influenced risk pathways: genetic loci impact problematic alcohol use via externalizing and specific risk. (2022)
- Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. (2022)
- Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. (2022)
- Large-scale collaboration in ENIGMA-EEG: A perspective on the meta-analytic approach to link neurological and psychiatric liability genes to electrophysiological brain activity. (2021)
- Using a developmental perspective to examine the moderating effects of marriage on heavy episodic drinking in a young adult sample enriched for risk. (2021)
- Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. (2021)
- Genetic association study of childhood aggression across raters, instruments, and age. (2021)
- The association of polygenic risk for schizophrenia, bipolar disorder, and depression with neural connectivity in adolescents and young adults: examining developmental and sex differences. (2021)
- Polygenic risk scores: from research tools to clinical instruments. (2020)
- Sibling comparisons elucidate the associations between educational attainment polygenic scores and alcohol, nicotine and cannabis. (2020)
- Tutorial: a guide to performing polygenic risk score analyses. (2020)
- Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
- Polygenic prediction via Bayesian regression and continuous shrinkage priors. (2019)
- Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement. (2019)
- Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. (2019)
- Linking genes, circuits, and behavior: network connectivity as a novel endophenotype of externalizing. (2019)
- The mutational constraint spectrum quantified from variation in 141,456 humans (2019)
- Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. (2019)
- Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. (2019)
- Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. (2019)
- The Impact of Peer Substance Use and Polygenic Risk on Trajectories of Heavy Episodic Drinking Across Adolescence and Emerging Adulthood. (2017)
Merged raw entities (30)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| polygenic risk score | drug | 40 | 143 |
| polygenic risk scores | drug | 24 | 39 |
| polygenic score | drug | 21 | 39 |
| polygenic scores | drug | 17 | 17 |
| polygenic risk score | phenotype | 16 | 28 |
| polygenic risk score (prs) | drug | 10 | 14 |
| polygenic score | phenotype | 10 | 19 |
| polygenic score (pgs) | drug | 7 | 8 |
| polygenic risk score | variant | 6 | 10 |
| polygenic risk scores | phenotype | 5 | 6 |
| ps | cohort | 3 | 11 |
| polygenic scores | phenotype | 2 | 2 |
| genetic risk scores | cohort | 1 | 1 |
| adjusted prs | cohort | — | — |
| common-variant prs | cohort | — | — |
| gps | cohort | — | — |
| highest prs decile | cohort | — | — |
| neuropsychiatric prs | cohort | — | — |
| pgss | cohort | — | — |
| polygenic risk | cohort | — | — |
| polygenic risk estimates | cohort | — | — |
| polygenic risk score | cohort | — | — |
| polygenic risk scores | cohort | — | — |
| polygenic score | cohort | — | — |
| polygenic scores | cohort | — | — |
| polygenic sum scores | cohort | — | — |
| prs | cohort | — | — |
| raw prs | cohort | — | — |
| tourette prs | cohort | — | — |
| trans-ancestry prs | cohort | — | — |